Cite
HARVARD Citation
Caffo, O. et al. (2015). Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients. Future oncology. pp. 965-973. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Caffo, O. et al. (2015). Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients. Future oncology. pp. 965-973. [Online].